Kidiamix G (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Kidiamix G provides a balanced mixture of essential and non‑essential amino acids that can be used in clinical situations where protein synthesis needs support.

• Protein‑energy malnutrition: helps restore nitrogen balance and promote tissue repair.
• Post‑operative recovery: supplies amino acids needed for wound healing and muscle rebuilding.
• Metabolic disorders with amino‑acid deficiency: assists in correcting specific deficits and stabilising metabolic pathways.

• The amino acids in Kidiamix G act as substrates for protein synthesis, serve as precursors for neurotransmitters and metabolic intermediates, and help maintain nitrogen balance. By delivering these building blocks directly into the circulation, the formulation supports cellular growth, tissue repair, and metabolic homeostasis without relying on gastrointestinal absorption.

Kidiamix G is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Injection site pain or erythema: mild discomfort at the infusion site.
• Nausea: transient feeling of queasiness.
• Headache: mild to moderate intensity.
• Transient hypernatremia: slight increase in serum sodium.
• Mild metabolic alkalosis: temporary shift in acid‑base balance.
• Flushing: brief warmth or redness of skin.

Serious or Rare Side Effects

• Anaphylactic reaction: severe hypersensitivity requiring immediate medical attention.
• Severe hypernatremia: marked elevation of serum sodium levels.
• Acute renal dysfunction: sudden decline in kidney function.
• Metabolic acidosis: significant disturbance in acid‑base status.
• Thrombophlebitis: inflammation of a vein with clot formation.
• Seizures: rare neurologic events linked to electrolyte shifts.

Kidiamix G should be administered under medical supervision with attention to patient-specific factors.

• Renal impairment: monitor renal function and adjust infusion rate if needed.
• Hepatic dysfunction: assess liver enzymes before and during therapy.
• Electrolyte disorders: correct existing imbalances prior to infusion.
• Pregnancy and lactation: use only if clearly indicated and benefits outweigh risks.
• Concomitant nutrition therapy: coordinate with other parenteral or enteral nutrition regimens.
• Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G may interact with other agents that affect amino‑acid metabolism or fluid balance.

Major Interactions (Avoid)

• High‑dose insulin therapy: may exacerbate hypoglycaemia due to increased amino‑acid uptake.
• Loop diuretics: can intensify electrolyte disturbances when combined with amino‑acid solutions.

Moderate Interactions (Monitor Closely)

• Renal‑active drugs (e.g., ACE inhibitors): watch for changes in serum creatinine.
• Other parenteral nutrition products: avoid overlapping amino‑acid provision to prevent excess load.
• Anticonvulsants (e.g., valproate): monitor for altered plasma amino‑acid levels.